ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
1,311
Screening encounters
1,373
Diagnostic referrals
254
Outstanding pathways
131

Screening pathway

  1. Screening1,373Encounters
  2. Positive finding458Documented findings
  3. Referral254Diagnostic referrals
  4. Follow-up272Diagnostic visits
  5. Outcome123Resolved pathways

Stage totals use different units. Pending pathways: 131. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4510 · EXP-4510Synthetic · Site C

Full participant history through 2025-08-29, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2025-09-03
  4. · Diagnostic referral · EXP-4510-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Missed
  8. · Diagnostic booking · Rebooking
  9. · Diagnostic visit · Attended
  10. · Diagnosis · Colposcopy · Biopsy collected
  11. · Diagnosis · Histopathology · No high-grade lesion identified
  12. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-07-09

Referral-time risk

Pathway status at observation · Pending

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

1311 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4490 · Expanded synthetic participant 4490Site D — Community Engagement Programme
EXP-4491 · Expanded synthetic participant 4491Site A — Urban Referral Hub
EXP-4504 · Expanded synthetic participant 4504Site C — Rural Outreach Programme
EXP-4510 · Expanded synthetic participant 4510Site C — Rural Outreach Programme
EXP-4511 · Expanded synthetic participant 4511Site A — Urban Referral Hub
EXP-4514 · Expanded synthetic participant 4514Site D — Community Engagement Programme
EXP-4515 · Expanded synthetic participant 4515Site E — Resource-Constrained Navigation Programme
EXP-4516 · Expanded synthetic participant 4516Site E — Resource-Constrained Navigation Programme
EXP-4526 · Expanded synthetic participant 4526Site D — Community Engagement Programme
EXP-4529 · Expanded synthetic participant 4529Site D — Community Engagement Programme
EXP-4535 · Expanded synthetic participant 4535Site C — Rural Outreach Programme
EXP-4545 · Expanded synthetic participant 4545Site C — Rural Outreach Programme
EXP-4548 · Expanded synthetic participant 4548Site A — Urban Referral Hub
EXP-4549 · Expanded synthetic participant 4549Site D — Community Engagement Programme
EXP-4552 · Expanded synthetic participant 4552Site A — Urban Referral Hub
EXP-4557 · Expanded synthetic participant 4557Site E — Resource-Constrained Navigation Programme
EXP-4560 · Expanded synthetic participant 4560Site C — Rural Outreach Programme
EXP-4563 · Expanded synthetic participant 4563Site E — Resource-Constrained Navigation Programme
EXP-4568 · Expanded synthetic participant 4568Site E — Resource-Constrained Navigation Programme
EXP-4569 · Expanded synthetic participant 4569Site E — Resource-Constrained Navigation Programme
EXP-4571 · Expanded synthetic participant 4571Site B — Peri-Urban Access Programme
EXP-4574 · Expanded synthetic participant 4574Site D — Community Engagement Programme
EXP-4575 · Expanded synthetic participant 4575Site B — Peri-Urban Access Programme
EXP-4579 · Expanded synthetic participant 4579Site E — Resource-Constrained Navigation Programme
EXP-4582 · Expanded synthetic participant 4582Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
592
HPV DNA
587
Cytology
194

Navigation activity

Barrier documented
201
Contact attempt
375
Navigation intervention
85
Diagnostic booking
309
Diagnostic visit
272

Documented barriers

Contact difficulty
64
Transport difficulty
64
Appointment coordination
73

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.